Trial site
Skin Cancer and Dermatology Institute
- 5running trials
- 7closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)8 trials
- Hidradenitis suppurativa2 trials
- Alopecia areata1 trial
- Melanoma1 trial
- Phase
- Phase 35 trials
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- Amgen4 trials
- Bluefin Biomedicine, Inc.2 trials
- Apollo Therapeutics Ltd1 trial
- Inmagene LLC1 trial
- Insmed Incorporated1 trial
- and 3 more
Running trials
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Active, not recruiting
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Active, not recruiting
A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis
Active, not recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)1 recruiting
Closed trials
Completed
Completed
Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe AD (Atopic Dermatitis)
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026